This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that the incidence of targeted malignant, thrombotic and autoimmune disorders after unrelated hematopoietic stem cell donation are similar between unstimulated BM and filgrastim-mobilized PBSC donors.
This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that the incidence of targeted malignant, thrombotic and autoimmune disorders after unrelated hematopoietic stem cell donation are similar between unstimulated BM and filgrastim-mobilized PBSC donors. Donors will undergo biennial surveys until study completion. Cases of targeted disorders will be reviewed by the medical monitors to confirm the veracity of the report.
Study Type
OBSERVATIONAL
Enrollment
21,974
Incidence of malignant myeloid hematologic disorders
To describe the long-term incidence of malignant myeloid hematologic disorders in donors who received and in those who did not receive filgrastim.
Time frame: Post HSCT donation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
City of Hope
Duarte, California, United States
National Marrow Donor Program Northern California & Northwest District
Oakland, California, United States
National Marrow Donor Program Southern California & Southwest District
Santa Ana, California, United States
Colorado Marrow Donor Program
Denver, Colorado, United States
OneBlood
Fort Lauderdale, Florida, United States
Hawaii Bone Marrow Donor Registry
Honolulu, Hawaii, United States
LifeSource
Glenview, Illinois, United States
Rock River Valley Blood Center
Rockford, Illinois, United States
Indiana Blood Center
Indianapolis, Indiana, United States
National Marrow Donor Program Southcentral District, Heart of America
Leawood, Kansas, United States
...and 19 more locations